A Study to Examine the Efficacy of the Arthritis Self Management Program

This study has been completed.
Sponsor:
Information provided by:
Alberta Bone and Joint Health Institute
ClinicalTrials.gov Identifier:
NCT00297726
First received: February 27, 2006
Last updated: NA
Last verified: February 2006
History: No changes posted
  Purpose

This study will examine the efficacy of the Arthritis Self Managemnet Program (ASMP)and determine changes in health resource utilization after completeing the ASMP program.


Condition Intervention
Osteoarthritis
Behavioral: Self-Management Program

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind
Primary Purpose: Educational/Counseling/Training
Official Title: A Prospective Study to Examine the Efficacy of the Arthritis Self Management Program (ASMP) in Patients With Osteoarthritis (OA) in Alberta

Resource links provided by NLM:


Further study details as provided by Alberta Bone and Joint Health Institute:

Primary Outcome Measures:
  • A difference in the WOMAC score of 20 percentage points

Secondary Outcome Measures:
  • A change in health care provider and medication utilization.

Estimated Enrollment: 64
Study Start Date: October 2004
Estimated Study Completion Date: April 2006
Detailed Description:

This study will provide an analysis of the efficacy of the Arthritis Self Management Program (ASMP) using both patient administered questionnaires as well as the health utilization data maintained within the administrative databases at Alberta Health and Wellness. This study will also provide other information that has not yet been evaluated in other arthritis self management studies including co-morbidity data and other specific health related utilization information that has not yet been evaluated in other arthritis self management studies including co-morbidity data and other specific health related utilization information as it is recorded in administrative databases, will include a control group and will adjust for potential confounding variables such as sex, age, body mass index (BMI) and stage of disease.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • OA of the hip and/or knee
  • Patient is 18 years of age and over

Exclusion Criteria:

  • a concurrent systemic inflammatory disease
  • Patient has previously participated in an arthritis self management educational program
  • Patient is awaiting total hip or total knee replacement surgery patient has a medical co-morbidity that would render the patient to participate fully in the study procedures, including terminal conditions such as chronic obstructive pulmonary disease, end stage renal disease, heart failure, malignancy with anticipated life expectancy of equal to or less than 2 years
  • Patient has been diagnosed with senile dementia or Alzheimer's disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00297726

Sponsors and Collaborators
Alberta Bone and Joint Health Institute
Investigators
Principal Investigator: Cyril B Frank, MD University of Calgary
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00297726     History of Changes
Other Study ID Numbers: PRO-OA-00001
Study First Received: February 27, 2006
Last Updated: February 27, 2006
Health Authority: Canada: Ethics Review Committee

Keywords provided by Alberta Bone and Joint Health Institute:
Osteoarthritis, Knee
Osteoarthritis, Hip
Osteoarthritis, Ankle
Arthritis
Self-Management

Additional relevant MeSH terms:
Arthritis
Osteoarthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases

ClinicalTrials.gov processed this record on September 18, 2014